Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. (Q55052510)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

object named as

Kok Hian Tan

17

0 references

object named as

Chuen Neng Lee

13

0 references

Gerard Pasterkamp

15

object named as

Gerard Pasterkamp

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

Dominique de Kleijn

16

object named as

Dominique P V de Kleijn

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

18

object named as

Sai Kiang Lim

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

1

object named as

Ruenn Chai Lai

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

5

object named as

Andre Choo

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Reida Menshawe El Oakley

14

object named as

Reida Menshawe El Oakley

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

author name string

Fatih Arslan

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Soon Sim Tan

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Betty Tan

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

May May Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Tian Sheng Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Bao Ju Teh

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

John Kun Long Eng

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Harwin Sidik

10

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Vivek Tanavde

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Wei Sek Hwang

12

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

48

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

1215-1224

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Mesenchymal stem cells: progress toward promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells and the treatment of cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells for cardiac regenerative therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Advances in cell-based therapy for structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Optimizing adult mesenchymal stem cells for heart repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Opportunities and challenges for mesenchymal stem cell-mediated heart repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Intestinal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Membrane vesicles as conveyors of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells: paradoxes of passaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells: clinical applications and biological characterization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Circulating microparticles in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Tissue factor-bearing microparticles and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microparticles, thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Cell-derived microparticles in haemostasis and vascular medicine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Endothelial microparticles in diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Potential roles of cell-derived microparticles in ischemic brain disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Basic mechanisms and pathogenesis of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microparticles and thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microvesicles: messengers and mediators of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Cell-derived microparticles: a new challenge in neuroscience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

The coagulopathy of acute promyelocytic leukaemia revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Tissue factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

The role of innate immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Therapeutic potential of plasma membrane-derived microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Identifiers

10.1016/J.YJMCC.2009.12.021

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

release_iu3czmfwvvc3pb4pjcu6a2ddae

1 reference

https://api.fatcat.wiki/v0/release/iu3czmfwvvc3pb4pjcu6a2ddae

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55052510&oldid=1835626331"